Pooled results found that β-agonists were associated with a two-fold increased risk for total mortality compared with corticosteroids, with marginal significance.
← all excerpts
Bronchodilators in COPD: impact of beta-agonists and anticholinergics on severe exacerbations and mortality.
1
—
—